Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.
Tanaka T, Hatakeyama S, Numakura K, Kido K, Noro D, Oikawa M, Hosogoe S, Tokui N, Yamamoto H, Narita S, Ito H, Yoneyama T, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C.
Tanaka T, et al. Among authors: numakura k.
Int J Urol. 2020 Dec;27(12):1095-1100. doi: 10.1111/iju.14363. Epub 2020 Sep 6.
Int J Urol. 2020.
PMID: 32893401